Cardiovascular Disease Research Study

This research study is evaluating an investigational drug that may help prevent major cardiac events such as heart attacks or strokes in patients at high risk of cardiovascular disease (CVD). CVD is the leading cause of death worldwide and is associated with high levels of low-density lipoprotein cholesterol (LDL-C). Available treatments like statins have been seen to reduce the risk of cardiac events by lowering the levels of LDL-C. Despite this, lots of people require a more intensive management especially those at a higher risk of major adverse cardiovascular events hence the purpose of this research.

The study may be an option if you:

Are aged 40-79 years of age.
Have an increased risk of cardiovascular disease.
Are on a stable and well-tolerated lipid-lowering therapy for at least the past 4 weeks.
Have no history of Heart attack, Stroke or Peripheral Arterial Disease.

Other criteria apply.

Qualified participants may receive the study drug and will receive study-related evaluations and care at no cost. You will receive $150 for each completed study visit and $150 for any unscheduled completed visits that may occur.

Submit to learn more:

Have you had one or more of the following cardiovascular events? (Heart Attack, Stroke, or Peripheral Arterial Disease)

Yes

Are you currently taking cholesterol medication? (ie: statins)

Yes

First Name *

Last Name *

DOB (month/day/year) *

Email Address *

Address (Town/City) *

Zip Code *

Phone Number (inc. area code)* *

**By registering and providing your telephone number, you agree to receive text messages from Accellacare for the purposes above at the number you provide. Message and data rates may apply. Message frequency will vary. No mobile information will be shared with third parties/affiliates for marketing/promotional purposes. For help, reply HELP to any message. To opt-out, reply STOP to any message.

Are you currently in another study? *

Yes

What is your preferred mode of contact? (Check all that apply) *

Phone Call

Text Message

Any

List any additional areas of research you may be interested in participating in outside of this trial.

When you register your interest with Accellacare (which is part of ICON plc), our team will add your information to our database, review your information and connect you with studies that you may be eligible for. When we find a match, Accellacare clinical research specialists will contact you directly for further pre-screening by phone and may refer you on to Accellacare sites or collaborating third-party sites for further on-site pre-screening. We may also contact you in the future by phone call, text message, or email regarding future trials you may be interested in based on the information you provide to us. The clinic you choose in the registration form below may be a third-party study site (which will be clearly indicated) that collaborates with Accellacare on clinical trials. If you select a third-party site, you agree that we may share your personal data with that clinic for further pre-screening. That clinic will be independently responsible for processing your personal data in accordance with all applicable data protection laws.

Data Protection

ICON plc is responsible for the personal data, including data related to your health, race, and ethnicity you choose to provide. We rely on your consent to add your information to our database, use this information to identify potentially appropriate clinical studies for you and contact you about them. When we call you for further pre-screening, note that these calls will be recorded. If you have selected a third-party site, we will share your information with this site so they can contact you for further pre-screening.

You can withdraw your consent at any time, for example by following instructions to do so in emails or text messages you receive from us, or by telling our patient recruitment team when speaking with them. This does not affect the lawfulness of the processing prior to your withdrawal. Additional information on how your data will be processed and how you can exercise your rights, can be found in our Privacy Policy. Please confirm if you consent to ICON plc collecting, using and sharing your personal data for the above purposes. *

I Agree

Please enter the security code: